Revision Optics scores panel-free win at FDA with Raindrop approval
This fall, patients with presbyopia are slated to have a new treatment option after the FDA gave a green light Wednesday to Lake Forest, Calif.-based Revision Optics' implantable Raindrop near vision inlay. It marks the first time the agency has approved a device that changes the shape of the cornea to improve vision.
Will innovation pay the price for med-tech biggering?
The urge to go on biggering and biggering and biggering has taken over the med-tech world. Barely a year after Zimmer and Biomet completed a $14 billion merger to become the second largest orthopedic device maker, the company now plans to spend another $1 billion to buy LDR and grow its spine business. (MDD Perspectives)
Closing of $175M Asia VC fund underlines core opportunities in the medical device space
HONG KONG In the midst of technological advancements that are disrupting the traditional health technology industry, some venture capital (VC) funds are reaping significant benefits by jumping into the medical device space in Asia in the formative days of the companies.